AzTrials
AzTrials

Atlantoaxial DislocationNCT05978375

A Prospective Cohort Study of for Surgical Treatment of Irreducible Atlantoaxial Dislocation

An observational study of Atlantoaxial Dislocation, run by Xuanwu Hospital, Beijing.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The management of irreducible atlantoaxial dislocation associated is challenging. Direct posterior distraction technique we proposed in 2010 could achieve satisfactory reduction. In 2020, we modified this technique and proposed a posterior intra-articular distraction technique. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Atlantoaxial Dislocation
What is being tested?
Posterior intra-articular distraction and fusion, Anterior transoral release and posterior cantilever reduction and fusion and TARP
Type of treatment
Surgery or procedure
How many people
100 participants
Where
No sites listed yet
Study dates
1 Sep 2023to 1 Sep 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 18-70, exclude traumatic, RA and previous surgery.

Who may be able to join

  • CT indicated atlantoaxial dislocation Agree with the operation plan Agree to be followed up

Who cannot join

  • The pathology is traumatic or RA Underwent operations in occipital-cervical region before With mortal diseases Without ability to sign papers

Trial locations and contacts

No sites are listed yet.

About this study

The management of irreducible atlantoaxial dislocation associated is challenging. Direct posterior distraction technique we proposed in 2010 could achieve satisfactory reduction. In 2020, we modified this technique and proposed a posterior intra-articular distraction technique. The intra-articular distraction technique could theoretically achieve satisfactory reduction and fusion. However, its superiority has not been proven. Therefore, we design a prospective study to compare the reduction rate and fusion rate of different strategies.

Being tested
Posterior intra-articular distraction and fusion, Anterior transoral release and posterior cantilever reduction and fusion, TARP

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Posterior intra-articular distraction and fusionProcedure or surgery

    Using reduction using posterior intra-articular distraction and fusion technique.

  • Anterior transoral release and posterior cantilever reduction and fusionProcedure or surgery

    Using anterior transoral release and posterior cantilever reduction and fusion technique.

  • TARPProcedure or surgery

    Using TARP technique.

Study groups in NCT05978375
Study groupRoleWhat they receive
Irreducible Atlantoaxial DislocationAtlantoaxial dislocation which could not be reducted under anesthesia traction with 1/6 weight.
Receives: Procedure: Posterior intra-articular distraction and fusion; Procedure: Anterior transoral release and posterior cantilever reduction and fusion; Procedure: TARP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fusion Rates

    Atlantoaixal fusion rates

    Measured: 12 months

Secondary outcomes (3)
  1. Japanese Orthopaedic Association Scores

    0-17 Scores

    Measured: 12 months

  2. Visual Analogue Scale

    0-10 Scores

    Measured: 12 months

  3. Neck Disability Index

    0-5 Scores

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2023
  2. Study start1 Sep 2023 (estimated)
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05978375
Sponsor's protocol ID
XW-NS-PROIAAD
Status last verified
Jul 2023
First submitted
30 Jul 2023
Last updated
23 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Chen Z, Duan W, Chou D, Guan J, Liu Z, Jian Q, Zhang B, Bo X, Jian F. A Safe and Effective Posterior Intra-Articular Distraction Technique to Treat Congenital Atlantoaxial Dislocation Associated With Basilar Invagination: Case Series and Technical Nuances. Oper Neurosurg. 2021 Mar 15;20(4):334-342. doi: 10.1093/ons/opaa391.

    PubMed 33372978

Questions about this trial

What is this clinical trial studying?

An observational study of Atlantoaxial Dislocation, run by Xuanwu Hospital, Beijing.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Zan Chen, MD (+8613911712120, chenzan66@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fusion Rates (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05978375, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in